Bellicum Pharmaceuticals Garners $139,650,000 New Funding Round

  • Feed Type
  • Date
    12/19/2014
  • Company Name
    Bellicum Pharmaceuticals
  • Mailing Address
    2130 West Holcombe Boulevard Houston, TX 77030 USA
  • Company Description
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases.
  • Website
    http://www.bellicum.com
  • Transaction Type
    IPO
  • Transaction Amount
    $139,650,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy